The outlook of companies tied to flagship drugs like Viagra presents a challenging investment landscape . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the patent expiration in key markets has introduced significant uncertainty . Investors are now grappling with the impact of riva